The FDA claimed that longer-lasting injectable version of Eli Lilly's schizophrenia drug, Zyprexa, appears effective, though a small number of patients experienced excessive sleepiness.

U.S. FDA warned that the review of Chantix tablets shows that the anti-smoking medication poses serious health risks and side effects.

The U.S. Food and Drug Administration does not inspect U.S. plants that produce high-risk medical devices as often as it is necessary and checks few manufacturing sites overseas.

On May 29, 2007 AstraZeneca, the maker of Prilosec (omeprazole) and Nexium (esomeprazole), sent FDA data from two long-term studies in patients with severe gastroesophageal reflux disease (GERD) that were being treated with either Prilosec or Nexium.

FDA Testing Confirms Presence of Salmonella Contamination

The U.S. Food and Drug Administration has cleared for marketing the Binax NOW Malaria Test, the first authorized U.S. rapid test for malaria, a mosquito-borne disease caused by a parasite. The test is intended for laboratory use.

Agrees to Halt Distribution Until Manufacturing Deficiencies Have Been Corrected

The U.S. Food and Drug Administration announced on June 22nd a final rule establishing regulations to require current good manufacturing practices (cGMP) for dietary supplements.

FDA Clears 'Computerized Medication Box' for U.S. Market

The U.S. Food and Drug Administration approved on June 21st Lyrica (pregabalin), the first drug fibromyalgia treatment, a disorder characterized by pain, fatigue and sleep problems.

Latest Effort in Strengthening U.S. Food Defense

Telik, Inc. (Nasdaq: TELK) announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Investigational New Drug (IND) application for TELCYTA® (canfosfamide HCl).